Latest Breaking News On - பரோமா சாட்டர்ஜி - Page 1 : comparemela.com

Revolut da una vuelta a su cúpula con fichajes para impulsar su operativa en el mundo | Compañías

Revolut da una vuelta a su cúpula con fichajes para impulsar su operativa en el mundo | Compañías
elpais.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from elpais.com Daily Mail and Mail on Sunday newspapers.

AustraliaJapanUnited statesIndiaUnited kingdomSingaporeIrelandLithuaniaAmericaSingaporeanAustraliansIrishmanJack shanahanParoma chatterjeeJoe heneghanUlster bank

Researchers closer to gene therapy that would restore hearing for the congenitally deaf

E-Mail CORVALLIS, Ore. - Researchers at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear. The work centers around a large gene responsible for an inner-ear protein, otoferlin. Mutations in otoferlin are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing. For a long time otoferlin seemed to be a one-trick pony of a protein, said Colin Johnson, associate professor of biochemistry and biophysics in the OSU College of Science. A lot of genes will find various things to do, but the otoferlin gene had appeared only to have one purpose and that was to encode sound in the sensory hair cells in the inner ear. Small mutations in otoferlin render people profoundly deaf.

Oregon state universityOregonUnited statesParoma chatterjeeSean bugelAayushi manchandaRobyn tanguayJosephine bonventreColin johnsonOregon state college of scienceNational institutes of healthCollege of scienceResearchers at oregon state universityCollege of agricultural sciencesMolecular biologyOregon state college

Researchers get closer to gene therapy that would restore hearing for congenitally deaf

Date Time Researchers get closer to gene therapy that would restore hearing for congenitally deaf CORVALLIS, Ore. – Researchers at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear. The work centers around a large gene responsible for an inner-ear protein, otoferlin. Mutations in otoferlin are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing. “For a long time otoferlin seemed to be a one-trick pony of a protein,” said Colin Johnson, associate professor of biochemistry and biophysics in the OSU College of Science. “A lot of genes will find various things to do, but the otoferlin gene had appeared only to have one purpose and that was to encode sound in the sensory hair cells in the inner ear. Small mutations in otoferlin render people profoundly deaf.”

Oregon state universityOregonUnited statesParoma chatterjeeSean bugelAayushi manchandaRobyn tanguayJosephine bonventreColin johnsonOregon state college of scienceNational institutes of healthCollege of scienceResearchers at oregon state universityCollege of agricultural sciencesMolecular biologyOregon state college

OSU researchers get closer to gene therapy to restore hearing for the congenitally deaf

OSU researchers get closer to gene therapy to restore hearing for the congenitally deaf OSU Colin Johnson of the OSU College of Science studies a protein essential to hearing CORVALLIS, Ore. (KTVZ) – Researchers at Oregon State University have found a key new piece of the puzzle in the quest to use gene therapy to enable people born deaf to hear. The work centers around a large gene responsible for an inner-ear protein, otoferlin. Mutations in otoferlin are linked to severe congenital hearing loss, a common type of deafness in which patients can hear almost nothing. “For a long time, otoferlin seemed to be a one-trick pony of a protein,” said Colin Johnson, associate professor of biochemistry and biophysics in the OSU College of Science. “A lot of genes will find various things to do, but the otoferlin gene had appeared only to have one purpose, and that was to encode sound in the sensory hair cells in the inner ear. Small mutations in otoferlin render people profoundly

Oregon state universityOregonUnited statesParoma chatterjeeSean bugelAayushi manchandaRobyn tanguayJosephine bonventreColin johnsonOregon state college of scienceNational institutes of healthCollege of scienceResearchers at oregon state universityCollege of agricultural sciencesMolecular biologyOregon state college

Revolut Supports COVID-19 Relief Efforts For India By Temporarily Waiving Fees On Cross-Border Remittance Payments

Revolut Supports COVID-19 Relief Efforts For India By Temporarily Waiving Fees On Cross-Border Remittance Payments announced on Monday it is temporarily waiving fees on cross-border remittance payments made to India, following the country’s latest surge in COVID-19 cases. As of this weekend, India has more than 400,000 COVID-19 cases and 7-day average of deaths more than 3,700. Revolut reported that the temporary waiving of fees is intended to help individuals who are remitting to India and supporting communities that are facing increasing medical costs or are not able to procure adequate medical equipment such as oxygen concentrators, during the country’s second COVID-19 wave. The platform is waiving international payment fees on external bank transfers into India for 30 days, starting today (May 10th). Speaking about the fee waiving,

IndiaParoma chatterjeeSaleh saeedRevolut indiaஇந்தியாபரோமா சாட்டர்ஜிஸாலெ சயீத்